Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20132
20144
20151
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AOP Orphan Pharmaceuticals AG3
CTI BioPharma2
Novartis Pharmaceuticals2
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Italfarmaco1
Protagonist Therapeutics, Inc.1
Ronald Hoffman1
University Hospital, Brest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera13
Hematologic Diseases6
Myeloproliferative Disorders6
Bone Marrow Diseases5
Thrombocythemia, Essential5
Primary Myelofibrosis4
Anemia2
Polycythemia2
Splenomegaly2
Thrombocytopenia2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.